| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005 | 4868 | 2005 |
| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 3879 | 2015 |
| The mutational landscape of lethal castration-resistant prostate cancer CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ... Nature 487 (7406), 239-243, 2012 | 2776 | 2012 |
| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2759 | 2015 |
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ... Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003 | 2024 | 2003 |
| Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ... Nature medicine 22 (3), 298-305, 2016 | 1561 | 2016 |
| Activating ESR1 mutations in hormone-resistant metastatic breast cancer DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ... Nature genetics 45 (12), 1446-1451, 2013 | 1224 | 2013 |
| Genomic correlates of clinical outcome in advanced prostate cancer W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ... Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019 | 1148 | 2019 |
| Integrative molecular concept modeling of prostate cancer progression SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ... Nature genetics 39 (1), 41-51, 2007 | 1099 | 2007 |
| An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ... Cancer cell 17 (5), 443-454, 2010 | 1016 | 2010 |
| Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ... Nature 448 (7153), 595-599, 2007 | 1005 | 2007 |
| Role of the TMPRSS2-ERG gene fusion in prostate cancer SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ... Neoplasia 10 (2), 177-IN9, 2008 | 905 | 2008 |
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ... Cancer cell 8 (5), 393-406, 2005 | 901 | 2005 |
| Recurrent gene fusions in prostate cancer C Kumar-Sinha, SA Tomlins, AM Chinnaiyan Nature Reviews Cancer 8 (7), 497-511, 2008 | 856 | 2008 |
| Integrative clinical genomics of metastatic cancer DR Robinson, YM Wu, RJ Lonigro, P Vats, E Cobain, J Everett, X Cao, ... Nature 548 (7667), 297-303, 2017 | 835 | 2017 |
| Identification of targetable FGFR gene fusions in diverse cancers YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ... Cancer discovery 3 (6), 636-647, 2013 | 798 | 2013 |
| Genomic hallmarks and structural variation in metastatic prostate cancer DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ... Cell 174 (3), 758-769. e9, 2018 | 704 | 2018 |
| TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer S Perner, F Demichelis, R Beroukhim, FH Schmidt, JM Mosquera, S Setlur, ... Cancer research 66 (17), 8337-8341, 2006 | 678 | 2006 |
| Repression of E-cadherin by the polycomb group protein EZH2 in cancer Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ... Oncogene 27 (58), 7274-7284, 2008 | 677 | 2008 |
| TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ... Cancer research 66 (7), 3396-3400, 2006 | 580 | 2006 |
